Alteri Wealth LLC Acquires Shares of 13,721 Kenvue Inc. (NYSE:KVUE)

Alteri Wealth LLC purchased a new stake in Kenvue Inc. (NYSE:KVUE - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 13,721 shares of the company's stock, valued at approximately $293,000.

Several other institutional investors and hedge funds also recently modified their holdings of KVUE. Kiley Juergens Wealth Management LLC raised its stake in Kenvue by 1.9% during the fourth quarter. Kiley Juergens Wealth Management LLC now owns 27,110 shares of the company's stock worth $579,000 after buying an additional 500 shares during the last quarter. Principle Wealth Partners LLC grew its stake in Kenvue by 3.7% during the fourth quarter. Principle Wealth Partners LLC now owns 14,194 shares of the company's stock worth $303,000 after purchasing an additional 500 shares during the period. White Pine Capital LLC increased its holdings in Kenvue by 1.0% in the fourth quarter. White Pine Capital LLC now owns 54,572 shares of the company's stock worth $1,165,000 after purchasing an additional 542 shares in the last quarter. Deseret Mutual Benefit Administrators lifted its stake in Kenvue by 29.0% in the fourth quarter. Deseret Mutual Benefit Administrators now owns 2,528 shares of the company's stock valued at $54,000 after buying an additional 568 shares during the period. Finally, SRS Capital Advisors Inc. boosted its holdings in shares of Kenvue by 67.4% during the 4th quarter. SRS Capital Advisors Inc. now owns 1,418 shares of the company's stock worth $30,000 after buying an additional 571 shares in the last quarter. 97.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

KVUE has been the topic of a number of research reports. Citigroup boosted their target price on shares of Kenvue from $21.00 to $22.00 and gave the company a "neutral" rating in a research report on Monday, April 14th. Redburn Atlantic initiated coverage on shares of Kenvue in a report on Thursday, April 10th. They set a "neutral" rating and a $23.50 price objective on the stock. Piper Sandler raised their target price on Kenvue from $24.00 to $27.00 and gave the company an "overweight" rating in a research note on Monday, February 24th. Barclays reduced their price objective on Kenvue from $23.00 to $22.00 and set an "equal weight" rating for the company in a research note on Monday, April 14th. Finally, Royal Bank of Canada reiterated a "sector perform" rating and issued a $24.00 target price on shares of Kenvue in a report on Monday, February 3rd. Eight research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $24.42.

Kenvue Stock Performance

NYSE:KVUE traded down $0.07 during trading on Tuesday, reaching $23.58. The company's stock had a trading volume of 15,082,402 shares, compared to its average volume of 17,016,987. Kenvue Inc. has a 12 month low of $17.67 and a 12 month high of $24.46. The firm has a market cap of $45.23 billion, a price-to-earnings ratio of 44.48, a price-to-earnings-growth ratio of 2.62 and a beta of 1.02. The firm has a 50 day moving average of $23.10 and a 200-day moving average of $22.53. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00.

Kenvue (NYSE:KVUE - Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The company reported $0.26 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.26. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. Research analysts expect that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 28th. Shareholders of record on Wednesday, May 14th will be issued a dividend of $0.205 per share. This represents a $0.82 annualized dividend and a yield of 3.48%. The ex-dividend date of this dividend is Wednesday, May 14th. Kenvue's dividend payout ratio (DPR) is 154.72%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.